Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Apr 15  •  12:11PM ET
6.91
Dollar change
+0.10
Percentage change
1.40
%
Index
-
P/E
-
EPS (ttm)
-1.06
Insider Own
1.82%
Shs Outstand
5.04M
Perf Week
6.56%
Market Cap
34.80M
Forward P/E
-
EPS next Y
-
Insider Trans
0.00%
Shs Float
4.95M
Perf Month
1.99%
Enterprise Value
109.63M
PEG
-
EPS next Q
-
Inst Own
1.26%
Perf Quarter
38.10%
Income
-9.23M
P/S
0.02
EPS this Y
-
Inst Trans
7.01%
Perf Half Y
55.87%
Sales
1.75B
P/B
-
EPS next Y
-
ROA
-2.65%
Perf YTD
169.73%
Book/sh
-11.11
P/C
0.40
EPS next 5Y
-
ROE
-
52W High
11.17 -38.18%
Perf Year
-9.14%
Cash/sh
17.36
P/FCF
-
EPS past 3/5Y
47.72% 33.28%
ROIC
-
52W Low
2.48 178.43%
Perf 3Y
-73.93%
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
-4.53% 8.01%
Gross Margin
5.76%
Volatility
5.69% 6.38%
Perf 5Y
-93.77%
Dividend TTM
-
EV/Sales
0.06
EPS Y/Y TTM
-1.34%
Oper. Margin
-0.08%
ATR (14)
0.44
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
0.58
Sales Y/Y TTM
-12.80%
Profit Margin
-0.53%
RSI (14)
55.51
Dividend Gr. 3/5Y
- -
Current Ratio
1.09
EPS Q/Q
18.28%
SMA20
5.58%
Beta
0.75
Payout
-
Debt/Eq
-
Sales Q/Q
-25.69%
SMA50
-3.32%
Rel Volume
0.26
Prev Close
6.81
Employees
-
LT Debt/Eq
-
SMA200
21.28%
Avg Volume
30.91K
Price
6.91
IPO
Sep 12, 2018
Option/Short
No / Yes
Trades
Volume
3,727
Change
1.40%
Date Action Analyst Rating Change Price Target Change
Apr-15-21Resumed Citigroup Buy $16
Apr-09-26 03:00AM
Dec-17-25 01:00AM
Sep-17-25 02:00AM
Jun-19-25 03:03AM
Apr-21-25 04:29PM
03:03PM Loading…
Mar-20-25 03:03PM
01:00AM
Mar-12-25 07:00AM
Feb-20-25 05:00AM
Feb-11-25 08:00AM
Jan-08-25 05:00AM
Nov-28-24 06:33AM
02:01AM
Nov-27-24 05:02AM
01:00AM
05:00AM Loading…
Nov-21-24 05:00AM
Nov-04-24 06:00AM
05:00AM
Oct-22-24 05:10AM
Oct-18-24 05:00AM
Oct-10-24 06:02AM
Sep-27-24 05:00PM
Sep-13-24 07:30AM
Aug-29-24 02:00AM
Aug-27-24 08:00AM
Jul-29-24 01:00AM
Jul-19-24 08:45AM
Jul-17-24 01:31AM
Jun-11-24 03:57AM
May-23-24 08:52AM
04:43AM Loading…
04:43AM
Apr-30-24 02:30AM
Mar-22-24 11:36AM
Mar-21-24 04:47AM
Mar-01-24 04:00AM
Feb-27-24 08:58AM
Dec-01-23 09:20AM
Nov-30-23 01:00AM
Nov-13-23 12:10AM
Aug-31-23 08:09AM
Aug-24-23 02:00AM
Jul-31-23 05:59AM
Jun-15-23 05:03AM
01:15AM
May-25-23 02:05AM
Mar-27-23 06:26AM
Mar-23-23 05:07AM
02:17AM
Mar-02-23 02:35AM
Feb-16-23 12:33AM
Dec-01-22 02:33AM
Nov-08-22 01:09AM
Sep-23-22 12:30AM
Sep-09-22 05:53AM
Aug-25-22 02:18AM
Aug-08-22 01:19PM
Aug-05-22 02:26AM
Jun-16-22 03:58AM
May-26-22 04:59AM
May-05-22 01:46PM
05:18AM
Apr-13-22 05:02AM
Mar-17-22 03:20AM
Mar-14-22 07:35AM
Mar-04-22 04:24AM
Mar-01-22 08:55AM
Feb-22-22 03:38AM
Jan-03-22 09:38PM
Nov-22-21 12:14PM
Nov-19-21 12:31AM
Nov-01-21 04:57PM
Oct-28-21 07:00PM
Oct-25-21 07:00AM
Sep-17-21 07:00AM
Sep-07-21 05:00AM
Aug-27-21 02:30AM
Aug-16-21 08:00AM
Aug-13-21 07:16AM
Aug-09-21 07:30AM
Aug-03-21 08:00AM
Jun-18-21 10:09AM
May-19-21 02:17AM
May-12-21 10:10AM
Apr-21-21 08:00AM
Mar-25-21 05:00AM
Mar-18-21 06:10AM
Mar-17-21 06:50AM
Mar-16-21 05:40AM
Feb-05-21 06:00AM
Jan-01-21 03:24AM
Dec-22-20 04:22AM
Nov-29-20 11:42AM
Nov-19-20 05:00AM
Oct-22-20 06:00AM
Oct-19-20 06:50AM
Oct-15-20 05:40PM
05:35PM
05:30PM
Sep-30-20 06:00AM
Sep-23-20 12:53PM
111, Inc. Is a holding company, which engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.